Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMBINE: Menopur and Bravelle in ART
NCT01417195Phase 4Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Jul 2011
- Primary completion
- Jan 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of urofollitropin in infertility (2 arms), sponsored by Ferring Pharmaceuticals. Primary endpoint: Fertilization Rate at Day 13. Started Jul 2011; status: completed.
02
Drugs
urofollitropin
03
Conditions
infertility
Beyond the preview
Go deeper on NCT01417195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01417195.